FBXW7 and GSK3β overexpression reduces CDX2 levels and function, causing growth arrest in colon cancer cells; disruption of both CDX2 phosphodegrons prevents FBXW7-mediated degradation. This evidence concerns the gene CDX2 and malignant colon neoplasm.